Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study
The objective of this article was to assess the safety and efficacy of long-term administration of PA21.
Source: Journal of Renal Nutrition - Category: Urology & Nephrology Authors: Fumihiko Koiwa, Keitaro Yokoyama, Masafumi Fukagawa, Tadao Akizawa Tags: Original Research Source Type: research